The effect of sildenafil citrate (Viagra®) on visual sensitivity

Journal of Vision

Volumn 7, Issue 8, 2007, Pages

  Stockman, Andrew ^a   Sharpe, Lindsay T ^a   Tufail, Adnan ^b   Kell, Philip D ^c   Ripamonti, Caterina ^a   Jeffery, Glen ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Light adaptation; PDE6; Sildenafil citrate; Temporal resolution; Temporal sensitivity; Viagra; Visual sensitivity; Visual transduction

Indexed keywords

PHOSPHODIESTERASE; PHOSPHODIESTERASE 6; PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SILDENAFIL; SULFONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CRITICAL FLICKER FUSION; DRUG EFFECT; HUMAN; MALE; RETINA CONE; TIME; VISION; VISUAL ADAPTATION;

ADAPTATION, OCULAR; ADULT; CONES (RETINA); FLICKER FUSION; HUMANS; MALE; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PIPERAZINES; PURINES; SULFONES; TIME FACTORS; VISION;

EID: 34250180913     PISSN: None     EISSN: 15347362     Source Type: Journal    
DOI: 10.1167/7.8.4     Document Type: Article

References (64)

1. Arshavsky, V. Y., Lamb, T. D., & Pugh, E. N., Jr. (2002). G proteins and phototransduction. Annual Review of Physiology, 64, 153-187. [PubMed]
2. Beavo, J. A. (1995). Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiological Reviews, 75, 725-748. [PubMed]
3. Birch, D. G., Toler, S. M., Swanson, W. H., Fish, G. E., & Laties, A. M. (2002). A double-blind placebo-controlled evaluation of the acute effects of sildenafil citrate (Viagra) on visual function in subjects with early-stage age-related macular degeneration. American Journal of Ophthalmology, 133, 665-672. [PubMed]
4. Boynton, R. M. (1979). Human color vision. New York: Holt, Rinehart and Winston.
5. Cunningham, A. V., & Smith, K. H. (2001). Anterior ischemic optic neuropathy associated with Viagra. Journal of Neuro-Ophthalmology, 21, 22-25. [PubMed]
6. De Lange, H. (1958a). Research into the dynamic nature of the human fovea-cortex systems with intermittent and modulated light: I. Attenuation characteristics with white and colored light. Journal of the Optical Society of America, 48, 777-784.
7. De Lange, H. (1958b). Research into the dynamic nature of the human fovea-cortex systems with intermittent and modulated light: II. Phase shift in brightness and delay in color perception. Journal of the Optical Society of America, 48, 784-789.
8. Eisner, A., & MacLeod, D. I. (1980). Blue-sensitive cones do not contribute to luminance. Journal of the Optical Society of America, 70, 121-123. [PubMed]
9. Eisner, A., & Samples, J. R. (2000). Flicker sensitivity and cardiovascular function in healthy middle-aged people. Archives of Ophthalmology, 118, 1049-1055. [PubMed]
10. Falsini, B., Riva, C. E., & Logean, E. (2002). Flicker-evoked changes in human optic nerve blood flow: Relationship with retinal neural activity. Investigative Ophthalmology & Visual Science, 43, 2309-2316. [PubMed] [Article]
11. Food and Drug Administration Joint Clinical Review (1998a). NDA-20-895 Section 4: Animal Pharmacology.
12. Food and Drug Administration Joint Clinical Review (1998b). Study 148-104: Phase I investigator-blind, placebo controlled, evaluation of safety, toleration, and pharmokinetics of sildenafil following escalating single oral doses in healthy male volunteers.
13. Food and Drug Administration Joint Clinical Review (1998c). Study 148-223: A double-blind, randomised, placebo controlled, four period crossover study to assess the effect of orally administered sildenafil (50, 100, 200 mg) on visual function in healthy male volunteers.
14. Food and Drug Administration Joint Clinical Review (1998d). Study 148-232: A randomised, double-blind, placebo-controlled, crossover pilot study to investigate the effects of a single oral tablet dose of sildenafil (200 mg) on visual function (electroretinogram, photostress, visual field and colour discrimination tests) in healthy male volunteers and patients with diabetic retinopathy.
15. Formaz, F., Riva, C. E., & Geiser, M. (1997). Diffuse luminance flicker increases retinal vessel diameter in humans. Current Eye Research, 16, 1252-1257. [PubMed]
16. Govardovskii, V. I., Calvert, P. D., & Arshavsky, V. Y. (2000). Photoreceptor light adaptation. Untangling desensitization and sensitization. Journal of General Physiology, 116, 791-794. [PubMed] [Article]
17. Guth, S. L., Alexander, J. V., Chumbly, J. I., Gillman, C. B., & Patterson, M. M. (1968). Factors affecting luminance additivity at threshold among normal and color-blind subjects and elaborations of a trichromatic-opponent color theory. Vision Research, 8, 913-928. [PubMed]
18. Gutherie, A. H., & Hammond, B. R., Jr. (2004). Critical flicker fusion frequency: Relation to resting systolic blood pressure. Optometry and Vision Science, 81, 373-376. [PubMed]
19. Hecht, S., & Verrijp, C. D. (1933). The influence of intensity, color and retinal location on the fusion frequency of intermittent illumination. Proceedings of the National Academy of Sciences of the United States of America, 19, 522-535. [PubMed] [Article]
20. Jägle, H., Jägle, C., Sèrey, L.,& Sharpe, L. T. (2005). Dose-dependency and time-course of electrophysiologic short-term effects of Viagra®: A case study. Documenta Ophthalmologica, 110, 247-254. [PubMed]
21. Jägle, H., Jägle, C., Sèrey, L., Yu, A., Rilk, A., Sadowski, B., et al. (2004). Visual short-term effects of Viagra: Double-blind study in healthy young subjects. American Journal of Ophthalmology, 137, 842-849. [PubMed]
22. Kelly, D. H. (1961). Visual response to time-dependent stimuli. I. Amplitude sensitivity measurements. Journal of the Optical Society of America, 51, 422-429. [PubMed]
23. Kotliar, K. E., Vilser, W., Nagel, E., & Lanzl, I. M. (2004). Retinal vessel reaction in response to chromatic flickering light. Graefe's Archive for Clinical and Experimental Ophthalmology, 242, 377-392. [PubMed]
24. Laties, A. M., Ellis, P., Koppiker, N., Patat, A., & Stuckey, B. (1998). Visual function testing in patients and healthy volunteers receiving VIAGRA. Ophthalmic Research, 30, 177.
25. Laties, A. M., Ellis, P., & Mollon, J. D. (1999). The effects of sildenafil citrate (VIAGRA) on color discrimination in volunteers and patients with erectile dysfunction. Investigative Ophthalmology and Visual Science, 40, S693.
26. Laties, A. M., & Fraunfelder, F. T. (1999). Ocular safety of Viagra, (sildenafil citrate). Transactions of the American Ophthalmological Society, 97, 115-125. [PubMed] [Article]
27. Laties, A., & Zrenner, E. (2002). Viagra® (sildenafil citrate) and ophthalmology. Progress in Retinal and Eye Research, 21, 485-506. [PubMed]
28. Luther, R. (1927). Aus dem Gebiet der Farbreizmetrik. Zeitschrift für technische Physik, 8, 540-558.
29. Luu, J. K., Chappelow, A. V., McCulley, T. J., & Marmor, M. F. (2001). Acute effects of sildenafil on the electroretinogram and multifocal electroretinogram. American Journal of Ophthalmology, 132, 388-394. [PubMed]
30. Marks, L. E., & Bornstein, M. H. (1973). Spectral sensitivity by constant CFF: Effect of chromatic adaptation. Journal of the Optical Society of America, 63, 220-226. [PubMed]
31. Marmor, M. F., & Kessler, R. (1999). Sildenafil (Viagra) and ophthalmology. Survey of Ophthalmology, 44, 153-162. [PubMed]
32. Matin, L. (1968). Critical duration, the differential luminance threshold, critical flicker frequency, and visual adaptation: A theoretical treatment. Journal of the Optical Society of America, 58, 404-415. [PubMed]
33. Mollon, J. D., & Polden, P. G. (1977). Saturation of a retinal cone mechanism. Nature, 265, 243-246. [PubMed]
34. Mollon, J. D., Regan, B. C., Foo, R., & Morris, B. J. (2003). Sildenafil increases persistence of vision. Investigative Ophthalmology and Visual Science, 44, 4097.
35. Morales, A., Gingell, C., Collins, M., Wicker, P. A., & Osterloh, I. H. (1998). Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. International Journal of Impotence Research, 10, 69-73. [PubMed]
36. Moreland, R. B., Goldstein, I., & Traish, A. (1998). Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cell. Life Sciences, 62, 309-318. [PubMed]
37. Nagel, E., & Vilser, W. (2004). Flicker observation light induces diameter response in retinal arterioles: A clinical methodological study. British Journal of Ophthalmology, 88, 54-56. [PubMed]
38. Nikonov, S., Lamb, T. D., & Pugh, E. N., Jr. (2000). The role of steady phosphodiesterase activity in the kinetics and sensitivity of the light-adapted Salamander rod photoresponse. Journal of General Physiology, 116, 795-824. [PubMed] [Article]
39. Pfizer (2007). Viagra website. [Link]
40. Polak, K., Wimpissinger, B., Berisha, F., Georgopoulos, M., & Schmetterer, L. (2003). Effects of sildenafil on retinal blood flow and flicker-induced retinal vasodilatation in healthy subjects. Investigative Ophthalmology & Visual Science, 44, 4872-4876. [PubMed] [Article]
41. Pomeranz, H. D., & Bhavsar, A. R. (2005). Nonarteric ischemic optic neuropathy developing soon after use of sildenafil (Viagra): A report of seven new cases. Journal of Neuro-Ophthalmology, 25, 9-13. [PubMed]
42. Pomeranz, H. D., Smith, K. H., Hart, W. M., Jr., & Egan, R. A. (2002). Sildenafil-associated nonarteric anterior ischemic optic neuropathy. Ophthalmology, 109, 584-587. [PubMed]
43. 1 colour mechanism of W. S. Stiles. The Journal of Physiology, 257, 713-747. [PubMed] [Article]
44. Pugh, E. N., Jr., & Lamb, T. D. (2000). Phototransduction in vertebrate rods and cones: Molecular mechanisms of amplification, recovery and light adaptation. In D. G. Stavenga, W. J. de Grip, & E. N. Pugh (Eds.), Handbook of biological physics Vol. 3: Molecular mechanisms of visual transduction (pp. 183-255). Amsterdam: Elsevier.
45. 3 color mechanisms of Stiles. Vision Research, 19, 293-312. [PubMed]
46. Pugh, E. N., Jr., Nikonov, S., & Lamb, T. D. (1999). Molecular mechanisms of vertebrate photoreceptor light adaptation. Current Opinion in Neurobiology, 9, 410-418. [PubMed]
47. Riva, C. E., Falsini, B., & Logean, E. (2001). Flicker-evoked responses of human optic nerve head blood flow: Luminance versus chromatic modulation. Investigative Ophthalmology & Visual Science, 42, 756-762. [PubMed] [Article]
48. Riva, C. E., Harino, S., Shonat, R. D., & Petrig, B. L. (1991). Flicker evoked increase in optic nerve head blood flow in anesthetized cats. Neuroscience Letters, 128, 291-296. [PubMed]
49. Schnapf, J. L., Nunn, B. J., Meister, M., & Baylor, D. A. (1990). Visual transduction in cones of the monkey Macaca fascicularis. The Journal of Physiology, 427, 681-713. [PubMed] [Article]
50. Schrödinger, E. (1925). Über das Verhältnis der Vierfarben zur Dreifarbentheorie. Sitzungberichte. Abt. 2a, Mathematik, Astronomie, Physik, Meteorologie und Mechanik. Akademie der Wissenschaften in Wien, Mathematisch-Naturwissenschaftliche Klasse, 134, 471.
51. Smith, V. C., & Pokorny, J. (1975). Spectral sensitivity of the foveal cone photopigments between 400 and 500 nm. Vision Research, 15, 161-171. [PubMed]
52. Stiles, W. S. (1953). Further studies of visual mechanisms by the two-colour threshold technique. Coloquio sobre problemas opticos de la vision, 1, 65-103.
53. Stiles, W. S. (1978). Mechanisms of colour vision. London: Academic.
54. Stockman, A., MacLeod, D. I., & DePriest, D. D. (1991). The temporal properties of the human short-wave photoreceptors and their associated pathways. Vision Research, 31, 189-208. [PubMed]
55. Stockman, A.,MacLeod, D. I.,& Lebrun, S. J. (1993). Faster than the eye can see: Blue cones respond to rapid flicker. Journal of the Optical Society of America A, Optics and image science, 10, 1396-1402. [PubMed]
56. Stockman, A., & Mollon, J. (1986). The spectral sensitivities of the middle- and long-wavelength cones: An extension of the two-colour threshold technique of W. S. Stiles. Perception, 15, 729-754. [PubMed]
57. Stockman, A., & Plummer, D. J. (1998). Color from invisible flicker: A failure of the Talbot-Plateau law caused by an early "hard" saturating nonlinearity used to partition the human short-wave cone pathway. Vision Research, 38, 3703-3728. [PubMed]
58. Stockman, A., Plummer, D. J., & Montag, E. D. (2005). Spectrally opponent inputs to the human luminance pathway: Slow +M and -L cone inputs revealed by intense long-wavelength adaptation. The Journal of Physiology, 566, 61-76. [PubMed] [Article]
59. Stockman, A., Sharpe, L. T., Tufail, A., Kell, P. D., & Jeffery, G. (2006). Viagra® slows the visual response to flicker. Current Biology, 16, R44-R45. [PubMed] [Article]
60. Stromeyer, C. F., III, Kronauer, R. E., & Madsen, J. C. (1979). Response saturation of short-wavelength cone pathways controlled by color-opponent mechanisms. Vision Research, 19, 1025-1040. [PubMed]
61. Vobig, M. A., Klotz, T., Staak, M., Bartz-Schmidt, K. U., Engelmann, U., & Walter, P. (1999). Retinal side-effects of sildenafil. Lancet, 353, 375. [PubMed]
62. Wallis, R. M., Casey, J., Howe, L., Leishman, D., & Napier, C. M. (1998). Characterisation of retinal phosphodiesterase (PDE) isozymes and the effects of sildenafil in vitro. Ophthalmic Research, 30, 111.
63. Walls, G. L. (1955). A branched-pathway schema for the color-vision system and some of the evidence for it. American Journal of Ophthalmology, 39, 8-23. [PubMed]
64. Wisowaty, J. J., & Boynton, R. M. (1980). Temporal modulation sensitivity of the blue mechanism: Measurements made without chromatic adaptation. Vision Research, 20, 895-909. [PubMed]